CRISPR Therapeutics Issues $600 Million Convertible Senior Notes

Marco Zingaro Europe Legal Chronicle
Tagged:

Walder Wyss has advised CRISPR Therapeutics. Davis Polk has advised the initial purchasers. CRISPR Therapeutics AG has successfully completed an offering of $600 million aggregate principal…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here